145 related articles for article (PubMed ID: 23298577)
1. Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers.
Gajbhiye V; Ganesh N; Barve J; Jain NK
Eur J Pharm Sci; 2013 Mar; 48(4-5):668-79. PubMed ID: 23298577
[TBL] [Abstract][Full Text] [Related]
2. Targeting potential and anti-HIV activity of lamivudine loaded mannosylated poly (propyleneimine) dendrimer.
Dutta T; Jain NK
Biochim Biophys Acta; 2007 Apr; 1770(4):681-6. PubMed ID: 17276009
[TBL] [Abstract][Full Text] [Related]
3. PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.
Gajbhiye V; Vijayaraj Kumar P; Tekade RK; Jain NK
Eur J Med Chem; 2009 Mar; 44(3):1155-66. PubMed ID: 18760863
[TBL] [Abstract][Full Text] [Related]
4. Stavudine-loaded mannosylated liposomes: in-vitro anti-HIV-I activity, tissue distribution and pharmacokinetics.
Garg M; Asthana A; Agashe HB; Agrawal GP; Jain NK
J Pharm Pharmacol; 2006 May; 58(5):605-16. PubMed ID: 16640829
[TBL] [Abstract][Full Text] [Related]
5. Intracellular macrophage uptake of rifampicin loaded mannosylated dendrimers.
Kumar PV; Asthana A; Dutta T; Jain NK
J Drug Target; 2006 Sep; 14(8):546-56. PubMed ID: 17050121
[TBL] [Abstract][Full Text] [Related]
6. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
7. Lactoferrin-conjugated dendritic nanoconstructs for lung targeting of methotrexate.
Kurmi BD; Gajbhiye V; Kayat J; Jain NK
J Pharm Sci; 2011 Jun; 100(6):2311-20. PubMed ID: 21491447
[TBL] [Abstract][Full Text] [Related]
8. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.
Dutta T; Agashe HB; Garg M; Balakrishnan P; Kabra M; Jain NK
J Drug Target; 2007 Jan; 15(1):89-98. PubMed ID: 17365278
[TBL] [Abstract][Full Text] [Related]
9. Targeting of efavirenz loaded tuftsin conjugated poly(propyleneimine) dendrimers to HIV infected macrophages in vitro.
Dutta T; Garg M; Jain NK
Eur J Pharm Sci; 2008 Jul; 34(2-3):181-9. PubMed ID: 18501568
[TBL] [Abstract][Full Text] [Related]
10. Formulation development and in vitro-in vivo assessment of the fourth-generation PPI dendrimer as a cancer-targeting vector.
Kesharwani P; Tekade RK; Jain NK
Nanomedicine (Lond); 2014 Oct; 9(15):2291-308. PubMed ID: 24593000
[TBL] [Abstract][Full Text] [Related]
11. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting.
Nimje N; Agarwal A; Saraogi GK; Lariya N; Rai G; Agrawal H; Agrawal GP
J Drug Target; 2009 Dec; 17(10):777-87. PubMed ID: 19938949
[TBL] [Abstract][Full Text] [Related]
12. The treatment of Glioblastoma Xenografts by surfactant conjugated dendritic nanoconjugates.
Gajbhiye V; Jain NK
Biomaterials; 2011 Sep; 32(26):6213-25. PubMed ID: 21616528
[TBL] [Abstract][Full Text] [Related]
13. Mannan-coated gelatin nanoparticles for sustained and targeted delivery of didanosine: in vitro and in vivo evaluation.
Kaur A; Jain S; Tiwary AK
Acta Pharm; 2008 Mar; 58(1):61-74. PubMed ID: 18337208
[TBL] [Abstract][Full Text] [Related]
14. Ligand anchored poly(propyleneimine) dendrimers for brain targeting: Comparative in vitro and in vivo assessment.
Patel HK; Gajbhiye V; Kesharwani P; Jain NK
J Colloid Interface Sci; 2016 Nov; 482():142-150. PubMed ID: 27501037
[TBL] [Abstract][Full Text] [Related]
15. Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.
Jain SK; Gupta Y; Jain A; Saxena AR; Khare P; Jain A
Nanomedicine; 2008 Mar; 4(1):41-8. PubMed ID: 18207463
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic targeting of zidovudine using surface-engineered liposomes.
Kaur CD; Nahar M; Jain NK
J Drug Target; 2008 Dec; 16(10):798-805. PubMed ID: 19005941
[TBL] [Abstract][Full Text] [Related]
17. Self-assembled drug delivery systems. Part 5: self-assemblies of a bolaamphiphilic prodrug containing dual zidovudine.
Jin Y; Qi N; Tong L; Chen D
Int J Pharm; 2010 Feb; 386(1-2):268-74. PubMed ID: 19941945
[TBL] [Abstract][Full Text] [Related]
18. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
19. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers.
Kuo JH; Jan MS; Lin YL
J Control Release; 2007 Jul; 120(1-2):51-9. PubMed ID: 17537537
[TBL] [Abstract][Full Text] [Related]
20. Characterization and evaluation of amphotericin B loaded MDP conjugated poly(propylene imine) dendrimers.
Jain K; Verma AK; Mishra PR; Jain NK
Nanomedicine; 2015 Apr; 11(3):705-13. PubMed ID: 25596078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
